Insmed (INSM) Change in Account Payables (2010 - 2022)
Insmed (INSM) recorded quarterly Change in Account Payables of -$16.9 million in Q2 2022, down 226.63% quarter-over-quarter from $13.4 million in Q1 2022, and down 285.64% on a YoY basis from $9.1 million in Q2 2021.
Insmed (INSM) Change in Account Payables (2010 - 2022) Analysis & Trends
Insmed's Change in Account Payables history runs 13 years deep, the most recent figure standing at -$16.9 million for Q2 2022.
- In Q2 2022, Change in Account Payables fell 285.64% year-over-year to -$16.9 million; the TTM figure through Jun 2022 stood at $25000.0 (down 99.61% YoY), while the FY2024 annual figure was $44.6 million, up 194.24% from the prior year.
- Change in Account Payables was -$16.9 million for Q2 2022 at Insmed, down from $13.4 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $20.7 million in Q4 2020 to a low of -$20.3 million in Q1 2021.
- Historically, Change in Account Payables has averaged $977555.6 across 5 years, with a median of $2.0 million in 2018.
- The sharpest annual moves came in 2019 and 2021: Change in Account Payables surged 1247.22% in 2019, then plunged 586.28% in 2021.
- A 5-year view of Change in Account Payables shows it stood at $1.3 million in 2018, then plunged by 577.96% to -$6.4 million in 2019, then soared by 424.73% to $20.7 million in 2020, then tumbled by 45.53% to $11.3 million in 2021, then sank by 250.02% to -$16.9 million in 2022.
- The last three Change in Account Payables figures came in at -$16.9 million (Q2 2022), $13.4 million (Q1 2022), and $11.3 million (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -9.42 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -16.92 Mn |
| Jun 30, 2022 | -16.92 Mn |
| Mar 31, 2022 | 13.36 Mn |
| Mar 31, 2022 | 13.36 Mn |
| Dec 31, 2021 | 11.28 Mn |
| Dec 31, 2021 | 11.28 Mn |
| Sep 30, 2021 | -7.70 Mn |
| Sep 30, 2021 | -7.70 Mn |
| Jun 30, 2021 | 9.12 Mn |
| Jun 30, 2021 | 9.12 Mn |
| Mar 31, 2021 | -20.27 Mn |
| Mar 31, 2021 | -20.27 Mn |
| Dec 31, 2020 | 20.71 Mn |
| Dec 31, 2020 | 20.71 Mn |
| Sep 30, 2020 | -3.06 Mn |
| Sep 30, 2020 | -3.06 Mn |
| Jun 30, 2020 | 8.01 Mn |
| Jun 30, 2020 | 8.01 Mn |
| Mar 31, 2020 | 4.17 Mn |
| Mar 31, 2020 | 4.17 Mn |